Analyst Ratings for Pasithea Therapeutics Corp. (KTTA)

KTTA Rating Summary

KTTA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on KTTA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $3.00 (+275%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/8/2025 H.C. Wainwright Sara Nik New Coverage Buy
(N/A)
3.00
(N/A)
1.13
(0.80)
-29.2% Details